Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cook Regentec
Indianapolis, Indiana, United States
- Ownership
- Private
- Employees
- ~36
- Development stage
- Other
01
Overview
Cook Regentec has initiated clinical trials for the HemaTrate Blood Filtration System for treating critical limb ischemia due to peripheral arterial disease, enrolling patients in an international clinical trial. Early clinical activity demonstrates capability to produce autologous, peripheral blood-derived total nucleated cell concentrates for therapeutic use.
- Therapeutic areas
- Cardiovascular
- Modalities
- DeviceSmall moleculeBiologicCell therapyGene therapy
- Industry
- Therapeutic Medical Devices
02
Partnerships
Indiana University School of Medicine
Beyond the preview
Go deeper on Cook Regentec.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cook Regentec.